Akero Therapeutics, Inc. announced the appointment of Patrick Lamy as Senior Vice President, Commercial Strategy. Patrick brings over 25 years of experience in building commercial teams, leading global product launches, and developing strategic plans to ensure the success of both large and small pharmaceutical companies. Most recently he served as VP, Commercial at Iovance Biotherapeutics, where he was responsible for all pre-launch commercial activities for the first cell therapy for melanoma and cervical cancer.

Prior to Iovance, Patrick held commercial roles of increasing responsibility at Gilead Sciences, notably playing a key role in launching Gilead's SOVALDI® and HARVONI® for HCV, as well as leading commercial planning for the company's liver disease portfolio. Patrick received his M.B.A. from the University of California, Water A. Haas School of Business.